Xequel Bio Revenue, Growth & Competitor Profile

DBA FIRST STRING RESEARCH, INC
DBA FSR

Company Profile & Annual Report for Xequel Bio

Access the complete profile.

Xequel Bio Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	1501 Belle Isle Ave Ste 220 Mount Pleasant, SC 29464

Note: Revenues for privately held companies are statistical evaluations.


Xequel Bio's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Xequel Bio's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Xequel Bio is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Xequel Bio Annual Revenue and Growth Rate

Xequel Bio	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Xequel Bio's revenues are gauged from an analysis of company filings.

Xequel Bio's Income Statement (based on Industry Averages)

Xequel Bio P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Xequel Bio has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
June 3, 2021	29	89%	$30 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Xequel Bio is developing and marketing. Xequel Bio doesn't have any recent trademark applications, indicating Xequel Bio is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
XEQUEL pharmaceutical and biological preparations utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, namely, ophthalmic eye drops useful in treating corneal injuries or ocular injury due to chemical agents, dermatological topical formulations useful in treating cutaneous radiation injuries, cutaneous scarring, and thermal burns, and inhalation solutions useful in treating acute lung injuries	05/03/2022
INEXIN Ophthalmic solution for medical and therapeutic treatment of eyes	06/07/2021
GRANEXIN Topical gel for medical and therapeutic treatment of wounds	10/11/2010

See all trademarks and details in the Full Report.

Market Share of Xequel Bio's Largest Competitors

A competitive analysis shows these companies are in the same general field as Xequel Bio, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Xequel Bio. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GEL GROUP	Charleston, SC	100
NCGS	Charleston, SC	15
COASTAL CAROLINA RESEARCH CENTER	North Charleston, SC	13
XEQUEL BIO	Mount Pleasant, SC	7
NEXGEN COMPOSITES	Summerville, SC	5
PALUSTRINE GROUP	Charleston, SC	3

Future Competition: Xequel Bio's Fastest Growing Competitors

These companies are in the same general field as Xequel Bio and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)